Mifepristone was approved for sale in the United States 15 years ago this month. Use of
mifepristone has steadily increased since its introduction; medical abortions now account for …

OBJECTIVE: To study the efficacy, safety, and acceptability of oral immediately swallowed
and buccal misoprostol 800 mcg after mifepristone 200 mg for terminating pregnancy …

Abstract Objective In January 2017, mifepristone became available in Canada. The goal of
this study was to determine the effectiveness and safety of mifepristone-misoprostol abortion …

The modern era of medical abortion treatment evolved with the development of mifepristone,
a progesterone-receptor antagonist with an affinity for the receptor greater than …

In September 2000, the Food and Drug Administration (FDA) approved mifepristone (also
known by the trade name Mifeprex or its original French name, RU-486) for use along with a …

This article provides information on recent changes in the US Food and Drug Administration
(FDA) labeling and safety regulations for mifepristone (Mifeprex). The revised label now …

The advent of early pregnancy termination with mifepristone and misoprostol promised the
availability of safe abortion services regardless of legal restrictions or women's access to …

OBJECTIVE: To demonstrate equivalence between mifepristone 200 mg followed 6 to 8
hours later and 24 hours later by misoprostol 800 μg vaginally for abortion in women up to …

Background It is not known whether a 400 μg dose of misoprostol has a similar efficacy as
an 800 μg dose when administered sublingually or vaginally 24 hours after 200 mg …

Please cite this paper as: von Hertzen H, Huong N, Piaggio G, Bayalag M, Cabezas E, Fang
A, Gemzell‐Danielsson K, Hinh N, Mittal S, Ng E, Chaturachinda K, Pinter B, Puscasiu L …